Breathe Well Live Well
|
Theron Pharmaceuticals to Present at the BIO-Europe Spring Conference on March …
Business Wire (press release) Dr. Zhang will provide a company overview and highlight Theron's lead COPD/asthma candidate, TRN-157, for which the company is actively seeking Biopharma partners on a global or regional basis to maximize its broad therapeutic potential in these … |
View full post on asthma – Google News
|
N30 Pharmaceuticals Announces Publication of S-Nitrosoglutathione Reductase …
Marketwire (press release) The report focuses on the lead chemical series which generated N30 N6022, a first in class GSNOR inhibitor currently in Phase 1b/2a trials for the treatment of asthma. GSNOR breaks down S-nitrosoglutathione (GSNO), and as such is an important regulator … |
View full post on asthma – Google News
|
Acton Pharmaceuticals, Inc. Submits NDA Supplement to FDA for AEROSPAN(R …
MarketWatch (press release) AEROSPAN is a hydrofluoroalkane (HFA) propelled inhaled corticosteroid for the treatment of asthma, which will compete in the $7 billion US inhaled steroid … |
View full post on asthma – Google News
|
Lotus Pharmaceuticals, Inc. (LTUS) Receives Phase I Approval for Asthma Drug
International Business Times Lotus Pharmaceuticals, Inc. said that research conducted by a third party indicated that the Asthma market in China is approximately $300 million annually, … Lotus Pharmaceuticals Receives SFDA Approval to Initiate Phase I Clinical … |
View full post on asthma – Google News
|
Lotus Pharmaceuticals Receives SFDA Approval to Initiate Phase I Clinical …
PR Newswire (press release) According to IMS Health, a pharmaceutical market research firm, the anti-asthma and chronic obstructive pulmonary disease market in China reached … |
View full post on asthma – Google News
|
Kos Pharmaceuticals and SkyePharma terminate license agreement for flutiform
Trading Markets (press release) Flutiform is used for adult and adolescent asthma. Under the terms of the agreement, Kos has the right to perform further clinical development for … Abbott, Skyepharma Part Ways On Asthma Drug Flutiform |
View full post on asthma – Google News
Cumberland Pharmaceuticals Reports First Quarter 2010 Earnings
NASHVILLE, Tenn., May 13 /PRNewswire-FirstCall/ — Cumberland Pharmaceuticals Inc.
Read more on redOrbit